As the debate over chemical abortion and its accessibility rages on, a new poll is showing that most American voters support stronger restrictions on the dangerous drugs.

A recent poll by McLaughlin & Associates discovered that 70% of American voters support reinstating the commonsense protections on chemical abortion drugs that the Food and Drug Administration under the Biden administration removed during the COVID-19 pandemic. Shockingly, this includes 57% of self-described “liberal” voters who say, at the very least, that in-person doctor’s visits be reinstated for the sake of women’s health and safety.

Prior to the COVID-19 pandemic, the FDA had commonsense protections on chemical abortion drugs that included the requirement that women visit a doctor in person before acquiring the pill. Yet during the pandemic, the Biden administration’s FDA lifted that pesky requirement under the guise that it would enable women to acquire the pill without risking catching the coronavirus.

In January 2023, the FDA made this change permanent — to the dismay and shock of those who recognized the dangers this held for women. The change, and its subsequent permanence, opened women to the possibility of poisoning by abusive partners, predators, pimps, or groomers who wanted them to end their pregnancies — and yes, this has happened several times. It has also left women vulnerable to the possibility that they could face severe life-threatening complications alone in their bathrooms, rather than under the guidance of a licensed medical professional.

Rather than moving to reinstate the protections for women’s health and safety, however, the “pro-choice” and “pro-woman” party has done everything in its power to ensure that the pills remain widely accessible and unrestricted.

Interestingly, however, public opinion apparently does not lie with the abortion industry on this one. The majority of the likely voters polled by McLaughlin & Associates, for example, are pro-abortion, including 36% who were “strongly” pro-abortion. This is shocking considering the poll’s revelation that most Americans have “significant doubts about the safety of the chemical abortion drug.”

These revelations come at an interesting time. Just recently, the Trump administration shocked and disappointed many pro-life advocates by quietly approving a new generic version of the chemical abortion drug mifepristone.

While pro-life advocates clamored against the decision — with leaders such as former Vice President Mike Pence calling the move “a complete betrayal of the pro-life movement that elected President Trump” — White House press secretary Karoline Leavvitt asserted that the FDA and the Health and Human Services Department were “merely following the law.” She claimed the decision to approve the new drug was “not an endorsement of this drug by any means.”

Even so, pro-life advocates are disappointed by the decision. On an Oct. 29 press call, Susan B. Anthony Pro-Life America President Marjorie Dannenfelser said that the approval “now makes the [abortion] pill far more available, far more accessible, and far cheaper,” adding that “this is something that we should be outraged at, and we are.”

HHS Secretary Robert F. Kennedy Jr. has promised to “review all the evidence—including real-world outcomes—on the safety of this drug.” He also claimed the FDA only approved the new generic version due to federal law, which “requires approval when an application proves the generic is identical to the brand-name drug.”

Now, pro-lifers, and apparently even some pro-abortion advocates, hope that the HHS and FDA find a sense of urgency in investigating and reinstating basic protections on the pill. Only time will tell if they will.